Status:
UNKNOWN
Efficacy of High Intensity Lazer Therapy in Partial Supraspinatus Tear
Lead Sponsor:
Izmir Katip Celebi University
Conditions:
Supraspinatus Tear
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
Rotatorcuff lesions constitute 10% of the causes of shoulder pain. Supraspinatus tear is one of the common rotatorcuff lesions. It affects the quality of life negatively and causes loss of range of mo...
Detailed Description
90 patients aged 20-60 years who were diagnosed with partial supraspinatus tear and met the inclusion criteria of the study will be included in the study. Patients will be randomized into three groups...
Eligibility Criteria
Inclusion
- age between 20-65 years
- Patients with VAS\>4 pain in the shoulder for at least 3 months
- Patients with at least 25% loss in the range of motion of the joint compared to the contralateral side, especially in abduction and external rotation, or on physical examination or positivity of at least one of the impingement tests including jobb, lift off, ERLS , speed, yergeson, O Brien's test, dropparm tests or popeye signs.
- Diagnose of partial supraspinatus with ultrasound or MR
Exclusion
- Patients with incomplete skin integrity, hyperemia, signs of infection or tattoos
- Patients with suspected full-thickness tear
- History of rheumatic disease (rheumatoidarthritis, osteoarthritis, PMR)
- Patients with accompanying shoulder pathology such as calcifictendinitis
- History of malignancy
- Surgery, manipulation, mobilization, arthroscopy performed on the affected shoulder
- Steroid, local anesthetic, hyaluronic acid injection, cnesiotaping or neural therapy in the affected shoulder in the last 3 months
- Reflex sympathetic dystrophy, neurodeficit in the affected extremity
- Diabetes patients or any Patients who cannot feel the burning pain due to a peripheral neuropathy or sensory defect
- Patients with epilepsy
Key Trial Info
Start Date :
December 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 2 2023
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05335785
Start Date
December 2 2020
End Date
December 2 2023
Last Update
April 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Izmir Katip Celebi University
Izmir, Karabaglar, Turkey (Türkiye), 35360